15 hours ago
Why AstraZeneca (AZN) Stock Fell Despite Crushing Q1 Earnings Expectations
AstraZeneca (AZN) shares dip despite beating Q1 forecasts with $15.29B revenue. Analysts say strong results were already baked into the stock price.
The post Why AstraZeneca (AZN) Stock Fell Despite Crushing Q1 Earnings Expectations appeared first on Blockonomi.
Source: Blockonomi →Related News
- 3 hours ago
Ondo Finance and Broadridge Unite to Bring Proxy Voting to Tokenized Stocks
- 5 hours ago
Securitize and Computershare Enable Tokenized Equity Issuance for Over 25,000 U....
- 7 hours ago
Should You Buy Advanced Micro Devices (AMD) Stock Ahead of Tuesday Earnings? Wal...
- 7 hours ago
Robinhood (HOOD) Stock Plummets 14% as Crypto Revenue Crashes 47%
- 8 hours ago
Seagate (STX) Stock Soars 10% as Analysts Target $1,000 Following Stellar Q3 Res...